IMA treatment normalized tumor microenvironment including PDGFR-β expression inhibition, tumor vessel normalization and tumor perfusion improvement, which enhanced the in vivo delivery of micelles around 23 nm but compromised that of nanoparticles around 110 nm. This evidence concerns the gene PDGFRB and neoplasm.